SageGuard Financial Group LLC Has $8.76 Million Stock Holdings in Colgate-Palmolive Company $CL

SageGuard Financial Group LLC decreased its position in Colgate-Palmolive Company (NYSE:CL) by 30.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 102,830 shares of the company’s stock after selling 44,615 shares during the period. Colgate-Palmolive accounts for 1.4% of SageGuard Financial Group LLC’s portfolio, making the stock its 22nd largest position. SageGuard Financial Group LLC’s holdings in Colgate-Palmolive were worth $8,764,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CL. Kemnay Advisory Services Inc. acquired a new position in Colgate-Palmolive in the fourth quarter valued at approximately $25,000. CBIZ Investment Advisory Services LLC boosted its stake in Colgate-Palmolive by 86.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company’s stock valued at $26,000 after acquiring an additional 150 shares during the last quarter. Jessup Wealth Management Inc acquired a new stake in Colgate-Palmolive during the 4th quarter worth $26,000. Triumph Capital Management grew its holdings in Colgate-Palmolive by 62.9% during the 4th quarter. Triumph Capital Management now owns 329 shares of the company’s stock worth $26,000 after acquiring an additional 127 shares during the period. Finally, TD Capital Management LLC raised its position in shares of Colgate-Palmolive by 61.4% during the 4th quarter. TD Capital Management LLC now owns 326 shares of the company’s stock valued at $26,000 after acquiring an additional 124 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of CL opened at $92.06 on Monday. The firm has a market cap of $73.66 billion, a P/E ratio of 35.82, a PEG ratio of 4.85 and a beta of 0.33. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $99.33. The company has a debt-to-equity ratio of 16.33, a quick ratio of 0.67 and a current ratio of 1.02. The firm’s 50 day moving average price is $88.07 and its two-hundred day moving average price is $87.12.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same quarter last year, the business posted $0.91 EPS. The company’s revenue for the quarter was up 8.4% on a year-over-year basis. On average, analysts forecast that Colgate-Palmolive Company will post 3.81 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be given a $0.53 dividend. The ex-dividend date of this dividend is Monday, July 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.3%. Colgate-Palmolive’s dividend payout ratio (DPR) is 82.49%.

Analysts Set New Price Targets

CL has been the topic of several recent research reports. UBS Group raised their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday, May 4th. Wells Fargo & Company dropped their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a report on Wednesday, April 8th. Morgan Stanley reissued an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. Bank of America reduced their target price on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Finally, Sanford C. Bernstein began coverage on Colgate-Palmolive in a research report on Thursday, June 11th. They set a “market perform” rating and a $96.00 target price for the company. Twelve investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.